BOTOX® Economic Spasticity Trial (BEST)

PHASE4CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

July 31, 2010

Conditions
Muscle Spasticity
Interventions
BIOLOGICAL

Botulinum Toxin Type A 900kD

"The exact dosage and number of injection sites is based on the size, number, and location of muscles involved; the severity of spasticity; and the presence of local muscle weakness.~First intra-muscular injection at the Baseline visit, and optional second injection of the randomised treatment after a minimum of 12 weeks to a maximum of 24 weeks following the Baseline visit."

BIOLOGICAL

Placebo

"The exact dosage and number of injection sites is based on the size, number, and location of muscles involved; the severity of spasticity; and the presence of local muscle weakness.~First intra-muscular injection at the Baseline visit, and optional second injection of the randomised treatment after a minimum of 12 weeks to a maximum of 24 weeks following the Baseline visit."

Trial Locations (4)

Unknown

Edmonton

Beelitz

Uppsala

Burslem

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00549783 - BOTOX® Economic Spasticity Trial (BEST) | Biotech Hunter | Biotech Hunter